Quest Diagnostics, Inc. (DGX) Tops Q1 EPS by 6c; Raises FY12 Outlook
Tweet
Share
E-mailGet Alerts DGX Hot Sheet
Price: $195.00 --0%
Revenue Growth %: +8.0%
Financial Fact:
Total operating costs and expenses: 1.56B
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +8.0%
Financial Fact:
Total operating costs and expenses: 1.56B
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Quest Diagnostics, Inc. (NYSE: DGX) reported Q1 EPS of $1.07, $0.06 better than the analyst estimate of $1.01. Revenue for the quarter came in at $1.94 billion versus the consensus estimate of $1.88 billion.
Raises its FY12 EPS guidance to $4.45-$4.60, which compares to the Street estimate of $4.54. The company previously guided to $4.40-$4.55.
For earnings history and earnings-related data on Quest Diagnostics, Inc. (DGX) click here.
Raises its FY12 EPS guidance to $4.45-$4.60, which compares to the Street estimate of $4.54. The company previously guided to $4.40-$4.55.
For earnings history and earnings-related data on Quest Diagnostics, Inc. (DGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ennis (EBF) Reports In-Line Q1 EPS
- Pfizer reaffirms 2026 guidance after CFO transition news
- Syensqo SA (SYENS:BB) PT Raised to EUR74 at Deutsche Bank
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
